Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
28.46
+0.50 (1.79%)
At close: Aug 31, 2026, 4:00 PM EDT
28.51
+0.05 (0.18%)
After-hours: Aug 31, 2026, 7:59 PM EDT

Pfizer Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Revenue
15,03414,45117,55716,65414,65313,71517,76317,70213,28314,87814,56913,49213,00718,48524,29022,63827,74225,66123,83824,035
Revenue Growth
2.60%5.37%-1.16%-5.92%10.31%-7.82%21.92%31.20%2.12%-19.51%-40.02%-40.40%-53.11%-27.96%1.90%-5.81%46.79%76.78%108.61%133.87%
Gross Profit
11,37911,04412,49212,67511,15211,12311,25012,82910,51511,84213,5034,5879,93513,73814,81516,60119,11715,70314,12714,135
Operating Income
4,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,7458,827
Net Income
-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,146
Earnings Per Share
-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.970.871.511.741.370.591.43
EPS Growth
--10.05%--21.31%6973.98%-5.30%---98.23%-43.40%---76.40%-29.10%47.11%5.50%77.42%59.09%289.72%450.37%

Revenue by Segment

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Primary Care
5,5035,5427,9387,6465,5355,6928,9119,0604,9527,2117,0446,3105,88411,56017,34815,84620,97918,85116,22516,680
Oncology
4,1653,826--4,0343,494--------------
Specialty Care
3,3532,939--3,0892,616--------------
Hospital and Biosimilars
1,6401,854--1,6471,639--------------
Business Innovation (Pfizer CentreOne)
373289409344348273325285278258364293307308368319317338382521
Revenue (Total)
15,03414,45117,55716,654-13,71517,76317,70213,28314,87914,56913,49113,00718,48625,13522,63827,74225,66123,83824,035

Cash & Debt

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Cash & Investments
11,70413,08113,59614,98613,24917,31920,4779,9537,10011,92912,69044,18244,78519,97222,73236,13233,31223,90231,07329,702
Total Debt
63,48064,73167,64761,93862,04462,39767,41867,94569,85869,90275,33264,13365,67436,16639,37736,99940,49036,44141,39539,879
Net Cash (Debt)
-51,776-51,650-54,051-46,952-48,795-45,078-46,941-57,992-62,758-57,973-62,642-19,951-20,889-16,194-16,645-867-7,178-12,539-10,322-10,177
Net Cash Growth
--------------------
Net Cash Per Share
-9.09-9.01-9.51-8.22-8.55-7.89-8.23-10.17-11.02-10.18-11.09-3.53-3.66-2.83-2.90-0.15-1.26-2.18-1.79-1.78

Cash Flow & CapEx

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Operating Cash Flow
8352,6155,3484,603-2,3356,7216,714-1,7811,0905,2403,456-1,2081,2128,5825,9748,1706,5415,91410,829
Capital Expenditures
-533-436-845-602--564-917-651-637-704-1,044-810-914-1,139-1,001-841-751-643-1,002-618
Free Cash Flow
3022,1794,5034,001-1,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,91210,211
Free Cash Flow Growth
-23.04%-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%2.08%545.04%

Margins

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Gross Margin
75.69%76.42%71.15%76.11%76.11%81.10%63.33%72.47%79.16%79.59%92.68%34.00%76.38%74.32%60.99%73.33%68.91%61.19%59.26%58.81%
Operating Margin
27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.69%21.44%37.14%25.59%44.83%44.29%40.33%28.29%36.73%
Pretax Margin
-4.34%21.93%-9.35%20.02%20.77%20.30%-0.06%26.64%-0.78%22.99%-28.34%-24.84%17.44%33.92%21.53%39.76%41.27%35.27%16.05%32.63%
Profit Margin
-1.65%18.59%-9.39%21.26%19.86%21.63%2.31%25.22%0.31%20.94%-23.12%-17.66%17.89%29.99%20.56%38.02%35.71%30.65%14.23%33.89%
FCF Margin
2.01%15.08%25.65%24.02%-12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.40%31.21%22.67%26.74%22.98%20.61%42.48%

Dividends

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Dividend Per Share
0.4300.4300.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.3900.390
Dividend Per Share Growth
0%0%2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%2.63%
Dividend Yield
9.01%8.22%9.08%9.59%9.54%9.29%8.93%6.57%6.89%7.01%6.82%5.96%5.42%4.89%3.91%4.58%3.84%3.90%3.41%4.70%

Valuation

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
PE Ratio
-20.54-13.7512.7918.1418.7238.77----9.647.939.178.2510.0111.6215.0812.39
Forward PE
8.549.138.548.468.598.559.9111.1812.2812.5419.2510.9411.4911.9510.827.657.787.1710.649.82
P/FCF Ratio
12.6014.4013.7811.67-12.7415.2920.04-30.7833.9222.90-11.4011.0510.5110.329.1211.108.09
PS Ratio
2.172.432.262.152.152.292.362.732.822.812.732.702.642.472.872.462.903.144.083.50